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A polarized epithelial culture system and chlamydia-specific T-cell lines and clones were employed to
investigate the ability and mechanisms by which T cells control the growth of chlamydiae in epithelial cells.
Monolayers of polarized mouse epithelial cells were infected with the Chlamydia trachomatis agent of mouse
pneumonitis (MoPn) and then exposed to antigen-stimulated MoPn-specific T-cell lines and clones. The results
revealed that in vivo-protective MoPn-specific T-cell lines and clone 2.14-0 were capable of inhibiting the
growth of MoPn in polarized epithelial cells. In contrast, the nonprotective MoPn-specific T-cell clone 2.14-3,
naive splenic T cells, and a control T-cell clone could not inhibit the growth of MoPn in epithelial cells.
Transmission electron microscopic analysis of infected epithelial cells which were exposed to clone 2.14-0
confirmed the absence ofan established infection, as deduced from the virtual absence of inclusions in the cells.
Antigen-specific activation of clone 2.14-0 was required for the MoPn-inhibitory function, since the absence of
antigenic stimulation or stimulation with a heterologous chlamydial agent did not result in MoPn growth
inhibition. Activation of clone 2.14-0 resulted in acquisition of the capacity to inhibit growth of both
homologous (MoPn) and heterologous chlamydial agents. Close interaction between epithelial cells and clone
2.14-0 was required for the MoPn-inhibitory action, because separation of the cell types by a filter with a pore
size of 0.45, 3.0, or even 8.0 ,um abrogated MoPn inhibition. Protective T cells may act at close range in the
epithelium to control chlamydial growth, possibly involving short-range-acting cytokines. The ability of
antigen-stimulated T-cell lines and clones to inhibit chlamydial growth in polarized epithelial cultures could
be a useful method for identifying protective T-cell
protective epitopes.
clones and antigenic peptide fragments containing
Chlamydial infections are widespread as both the most
common sexually transmitted disease in the United States and
the cause of trachoma, the world's leading cause of preventable
blindness (36). Pelvic inflammatory disease is a major compli-
cation of chlamydial genital disease in women and may lead to
fallopian tube damage and infertility (32).
The genital or ocular mucosal epithelium is the target of
chlamydial infection, and specific infection-driven mononu-
clear cell infiltration and lymphoepithelial interactions are
associated with the exposure (22, 23, 38). These interactions do
lead to the elicitation of antichlamydial immune responses,
with resultant development of specific immunity and resolution
of disease (6, 11, 13, 27, 28). Humoral immunity as well as
cell-mediated immunity have been found to have protective
functions in chlamydial genital disease (12, 21, 25-27, 31).
Paradoxically, T-cell-mediated antichlamydial immune re-
sponses, possibly directed at specific chlamydial antigens on
the epithelium during recurrent and/or persistent infections,
are also responsible for the pathogenesis of conjunctival
scarring in trachoma (7, 19, 37) and possibly pelvic inflamma-
tory disease-associated fallopian tube damage as well (40).
We have been studying the T-cell immune mechanisms
involved in the resolution of chlamydial genital infection in the
murine model of the disease. In this system, when immuno-
competent +/nu mice (H-2d) are infected intravaginally with
the Chlamydia trachomatis biovar agent of mouse pneumonitis
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(MoPn), the infection is resolved within 3 weeks. T-cell
immunity alone in the absence of humoral immunity is capable
of bringing about the resolution of chlamydial genital infection
in susceptible mice (8, 9, 24, 25, 30). Thus, B-cell-deficient mice
could resolve the disease as efficiently as immunocompetent
mice (25). Also, athymic nu/nu mice, which are normally
incapable of resolving the infection (30), can be cured of the
disease by adoptive transfer of MoPn-specific T-cell lines (24)
or clones (8, 9).
Studies with in vitro models consisting of polarized epithelial
(and nonepithelial) cell cultures have indicated that a major
mechanism of chlamydial colonization of the epithelium is
receptor-mediated endocytic internalization in clathrin-coated
pits (46). However, no information is currently available on the
nature or types of lymphoepithelial interactions or their effects
on chlamydial colonization of the epithelium and the intracel-
lular growth of the pathogen or how such interactions lead to
protective immunity or immunopathology of chlamydial dis-
ease. Knowledge of the cellular and molecular mechanisms of
genital or ocular lymphoepithelial interactions during chla-
mydial infection and their effects on chlamydial colonization,
multiplication, and spread in the genital or ocular epithelium is
important for present efforts to design and develop vaccines
against the disease (4).
To understand the cellular and molecular mechanisms of
T-cell restriction of chlamydial growth in the epithelium and
the immunopathogenic mechanisms of epithelial injury by
antichlamydial cell-mediated immunity, we have begun a sys-
tematic investigation of the effect of lymphoepithelial interac-
tions on chlamydial infection by using a polarized epithelial-
lymphocyte coculture (PELC) system. These studies involve
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the establishment of cultures of polarized mouse epithelial
cells, infection with MoPn, and exposure of infected cells to
MoPn-specific T-cell lines and clones. The T-cell lines and
clones have been characterized as either protective or nonpro-
tective on the basis of their ability to cure genital MoPn
infection in nude mice (8, 9, 24). The PELC system is especially
suitable for these studies because under normal physiologic
conditions epithelial cells are polarized in their organization,
and the interaction with immune cells results in control of
chlamydial infection. The present report describes the adapted
PELC system and its use for examining the effect of T cells on
the productive growth of MoPn in epithelial cells.
MATERIALS AND METHODS
Animals. Female +/nu mice on a BALB/c background
(H-2d), 5 to 6 weeks old, were obtained from Harlan Sprague-
Dawley, Inc., Indianapolis, Ind., and maintained in Plexiglas
isolators under pathogen-free conditions. The animals were
fed with food and water ad libitum under 12-h-light and
12-h-dark conditions.
Cultivation of chlamydiae and preparation of antigens.
Chlamydial stocks used for infecting polarized epithelial
monolayers were prepared according to standard techniques
using HeLa cells, as previously described (25). Antigens from
MoPn, C. trachomatis serovar E, and the Chlamydia psittaci
agent of guinea pig inclusion conjunctivitis (GPIC) were
prepared by purification of elementary bodies (EBs) from
stocks with Renografin gradients (25) and exposing the EBs to
UV light for 3 h.
Epithelial cells and polarized epithelial cell culture. The
epithelial cell line employed for these studies, TM3 (ATCC
CRL 1714), was derived from Leydig cells of BALB/c +Inu
mice (H-2d). The cells have normal or primary epithelial cell
culture characteristics (17) and are nontumorigenic. They are
responsive to luteinizing hormone (by an increase in cyclic
AMP secretion) but are nonresponsive to follicle-stimulating
hormone. TM3 cells express receptors for estrogen, epidermal
growth factor, androgen, and progesterone and secrete pros-
taglandin F2. The cell line was adapted to and maintained in
culture in RPMI 1640 complete medium, composed of RPMI
1640 (Hazelton Research Products, Denver, Pa.) supple-
mented with 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-
2-ethanesulfonic acid) (GIBCO Laboratories, Grand Island,
N.Y.), 10% heat-inactivated fetal bovine serum (GIBCO), 1.0
mM sodium pyruvate, 0.1 mM nonessential amino acids, 2 mM
glutamine, 2 x 10'- mM 2-mercaptoethanol (Sigma Chemical
Co., St. Louis, Mo.), 50 jig of gentamicin per ml or 100 U of
penicillin per ml (GIBCO), and 100 jig of streptomycin per ml
(GIBCO). We have established that chlamydial agents em-
ployed in these studies (MoPn, GPIC, and C. trachomatis
serovar E) grow efficiently in TM3 cells in culture.
To establish monolayers of polarized epithelial cell cultures
that mimic the in vivo architecture of the mucosal epithelium,
1 x 106 to 2 x 106 TM3 cells were seeded into the inner
chamber of multi-well Transwell plates (24-mm diameter,
collagen-coated polycarbonate filter; pore size, 0.45 ,um; cata-
log no. 2435; Costar, Cambridge, Mass.) according to the
method of Wyrick and coworkers (46). The polarized mono-
layer is attained after 24 to 48 h of culture at 37°C. Centrifu-
gation did not affect the polarization of the cells as determined
by inverted microscopic observation.
Infection of polarized epithelial cell cultures. Unless other-
wise stated, infection of polarized epithelial monolayers was
carried out with 103 inclusion-forming units (IFU) of MoPn or
GPIC in a volume of 0.25 ml of the growth medium. The outer
TABLE 1. Properties of T-cell preparations employed in the studies
Atgn Ability to resolveT cells Phenotype specificity chiamydialspecificity2-4oinfe tion'
Clone 2.14-0 CD4+ MoPn Yes
Clone 2.14-3 CD4+ MoPn No
Clone TC08AA-5 CD4+ Allospecific No
T-cell lines (JR1 CD4+ CD8+ MoPn Yes
and JR2)
NSTCb CD4+ CD8+ None No
a Resolution of disease was established by at least three consecutive negative
isolation attempts from cervicovaginal swabs.
b NSTC, normal splenic T cells.
chamber contained 2 ml of the growth medium. Infected
epithelial cells were centrifuged at 2,060 x g for 30 min.
Production of MoPn-specific T cells and clones. Table 1
summarizes the general characteristics of the T-cell prepara-
tions employed in these studies. The isolation procedure and
properties of the three T cell lines and clones employed in
these studies have been previously described (8). Briefly,
clones 2.14-0 and 2.14-3 are both MoPn-specific, CD4+ T cells
that were generated by the limiting dilution technique from
splenic cells of MoPn-infected +/nu mice. Both clones are
antigen specific, major histocompatibility complex restricted,
and biovar specific, since they do not respond to stimulation by
C. trachomatis serovar E or GPIC. While cultures of antigen-
stimulated 2.14-0 contained interleukin-2 and high levels of
gamma interferon (IFN-y) and tumor necrosis factor alpha
(TNF-a), identical cultures of clone 2.14-3 contained relatively
lower levels of IFN--y (at least fivefold less) and nondetectable
levels of TNF-ot. In addition, when 107 cells of each clone were
adoptively transferred into nude mice with established genital
MoPn infection, only clone 2.14-0 was capable of curing the
recipients.
Clone TC08AA-5 is an allospecific CD4+ clone, employed
as an irrelevant control in the studies. It was generated by
stimulating +Inu splenic T cells with C57BL/6 splenic stimu-
lator cells in a one-way mixed-leukocyte culture and cloned by
the limiting dilution method (8, 9).
Other T-cell preparations employed in these studies include
short-term MoPn-responsive T-cell lines (JR-1 and JR-2)
generated by restimulating and expanding MoPn-immune T
cells with MoPn, antigen-presenting cells (APCs), and con-
canavalin A-conditioned medium as previously described (8)
and normal splenic T cells prepared by combined nylon-wool
and glass bead purification of spleen cells from naive +/nu
mice, which yielded at least 99% CD3+ T cells as analyzed by
fluorescence-activated cell sorting (24).
Exposure of chlamydia-infected polarized epithelial cells to
T cells. All T-cell lines and clones were harvested and purified
over Ficoll gradients in order to enrich for viable cells before
they were used in these experiments. T cells (2.5 x 106 per
well) were stimulated for 24 to 48 h in six-well tissue culture
plates with 20 x 106 APCs and 10 jig of antigen per ml in a
final volume of 2.0 ml. APCs were prepared by irradiating
spleen cells from naive +/nu mice with 2,000 rads of X
irradiation followed by subsequent washing in HEPES-buff-
ered RPMI 1640 medium. Exposure of infected epithelial cells
to activated T cells was carried out by two general methods. (i)
The Transwell tissue culture inserts containing infected epi-
thelial cells were transferred into culture wells containing
stimulated T cells, in which case the infected epithelial cells
were suspended in the culture supernatants of the T cells. In
this method, the activated T cells and the infected epithelial
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cells were physically separated by a filter with a pore size of
0.45 ,um. (ii) The stimulated T cells (with or without the
supernatants) were transferred into the Transwell inserts con-
taining infected epithelial cells (coculturing). In this case, the T
cells and the infected epithelial cells were physically in contact
with one another. T-cell-exposed cultures and controls were
incubated for 48 h.
Assessment of chlamydial growth in polarized epithelial
cells. At the end of the 48-h incubation period, the superna-
tants were aspirated from the infected epithelial cells and the
filters were carefully cut out with sterile surgical blades, placed
in double-sucrose phosphate medium, and stored at -70°C.
The productive growth of chlamydiae (MoPn or GPIC) in
polarized epithelial cells in the presence or absence of T cells
was determined by isolation of the organism from the filter
samples in McCoy cells and detection of chlamydial inclusions
by microimmunofluorescence assay (25). Each set of isolation
experiments was repeated at least three times in order to
obtain a quantifiable and consistent pattern of results.
TEM studies. Transmission electron microscopic (TEM)
studies were conducted with infected epithelial samples in
order to determine the nature of the chlamydial inclusions
when MoPn-infected epithelial cells were exposed to chlamy-
dia-specific T cells. Following exposure of MoPn-infected
polarized epithelial cells to specific T-cell clones and lines for
48 h, the filters containing the infected epithelial cells were
washed and fixed in situ with 2% glutaraldehyde-0.5%
paraformaldehyde in 0.1 M cacodylate buffer for 45 min at
37°C. Fixed filter samples were cut out and dipped in 2%
molten Noble agar and processed in Epon 812 resin for TEM
as previously described (46).
Statistical analysis. The degrees of inhibition of MoPn by
different preparations and various numbers of T cells were
compared by performing a one-tailed t test, with minimal
statistical significance judged at P < 0.05.
RESULTS
Effect of MoPn-specific T cells on productive growth of
MoPn in polarized epithelial cells. We employed a PELC
system to investigate the nature and mechanism of lymphoepi-
thelial interactions that culminate in T-cell immune responses
against chlamydiae in the mucosal epithelium. In order to
establish that specific T-cell-epithelial cell interactions could
control chlamydial colonization of the epithelium, the initial
studies were designed to test the effect of exposing chlamydia-
infected polarized epithelial cells to antigen-stimulated T cells
on the productive growth of chlamydiae. The characteristics
and sources of T cells employed in these studies, as given in
Table 1, are as follows: (i) MoPn-specific T-cell clones that
were either capable of curing established genital MoPn disease
in nude mice when adoptively transferred into diseased mice
(protective T-cell clones) or were incapable of curing the
genital infection (nonprotective T-cell clones); (ii) MoPn-
reactive T-cell lines (protective); (iii) an irrelevant allospecific
control T-cell clone (nonprotective); and (iv) nylon-wool-
purified naive splenic T cells (nonprotective).
To determine whether chlamydia-specific T cells could in-
fluence the multiplication of chlamydiae in epithelial cells,
replicate cultures of polarized TM3 epithelial cells were estab-
lished in Costar's Transwell plates and infected with 103 IFU of
MoPn. Within 30 min of infection, the epithelial cells were
cocultured with antigen-stimulated MoPn-specific T-cell
clones and other T-cell preparations for 48 h. Transwell filters
containing infected epithelial cells were harvested at the end of



















FIG. 1. Effect of exposing MoPn-infected polarized epithelial cells
to MoPn-specific T-cell lines and clones. MoPn-infected polarized
epithelial cells were cocultured with each T-cell preparation (2.5 x 10'
per well) in duplicate wells of Transwell plates. T-cell-exposed cultures
and controls were incubated for 48 h, and MoPn growth was assessed
by tissue culture isolation and detection of inclusion bodies by the
microimmunofluorescence method. Results are expressed as percent
inhibition calculated as follows:
mean IFU/ml of control cultures (no T cells) - mean IFU/ml
of experimental cultures (+T cells) x 100
mean IFU/ml of control cultures (no T cells)
productive growth of MoPn in polarized epithelial cells was
determined by isolation of MoPn from the harvested filters and
detection of the inclusion bodies by the microimmunofluores-
cence technique. Figure 1 shows that when protective and
nonprotective T-cell preparations were cocultured with MoPn-
infected polarized epithelial cells, the protective T-cell lines
(JR-1 and JR-2) and clone 2.14-0 could limit the productive
growth of MoPn in epithelial cells. Nonprotective T-cell clone
2.14-3 and the control allospecific T-cell clone (TC08AA-5) or
naive splenic T cells could not inhibit the growth of MoPn in
polarized epithelial cells. These data were substantiated by
exposure of MoPn-infected TM3 cells to three other nonpro-
tective MoPn-reactive T-cell clones of both CD4 and CD8
phenotypes; again, no inhibition of MoPn multiplication oc-
curred (data not shown).
We also investigated whether the ability of clone 2.14-0 to
inhibit the growth of MoPn in polarized epithelial cells was
dependent upon the stage of the infection, such as the length
of time after infection before the epithelial cells were exposed
to T cells. This was done because the infected epithelial cells
were normally cocultured with T cells within 30 min of
infection. To address whether the MoPn-inhibitory action of
clone 2.14-0 was dependent upon the stage of the infection, the
coculturing of infected epithelial cultures with clone 2.14-0 was
delayed for 24 h after the infection. When the growth of MoPn
inclusions was determined, it was observed that the delay of 24
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h before the exposure of infected epithelial cells to protective
T-cell clone 2.14-0 did not affect the ability of the clone to limit
the productive growth of MoPn in the polarized epithelial cells
(data not shown).
These results indicated that chlamydial multiplication in
epithelial cells can be inhibited by chlamydia-specific T cells in
vitro and the inhibition is effective even when the infectious
process has initiated in the epithelial cells. Further, it appears
that only in vivo protective T cells could inhibit chlamydial
growth in polarized epithelial cells in vitro, suggesting that a
common mechanism of antichlamydial action may be involved.
We additionally wanted to compare the nature of chlamydial
inclusions formed in polarized epithelial cells in the presence
or absence of protective and nonprotective T cells. In such
investigations, TEM studies were conducted on infected epi-
thelial cell cultures that were either exposed or not exposed to
protective and nonprotective T cells. Figure 2 represents the
transmission electron photomicrographs of MoPn-infected po-
larized epithelial cell cultures, which were exposed to culture
medium alone (Fig. 2A and B, enlarged inclusion) or to the
protective clone 2.14-0 (Fig. 2C) and the irrelevant T-cell clone
TC08AA-5 (Fig. 2D). MoPn inclusion bodies are detectable in
infected epithelial cells that were exposed to medium alone
(Fig. 2A and B) or cocultured with nonprotective clone
TC08AA-5 (Fig. 2D). In contrast, no inclusions are detectable
in infected epithelial cells that were cocultured with the
protective clone 2.14-0 (Fig. 2C). The result indicated that
protective T cells may control chlamydial disease by limiting
the development of inclusions in the infected cells.
Effects of T-cell numbers and MoPn inocula on the ability of
clone 2.14-0 to inhibit MoPn growth in polarized epithelial
cells. We investigated whether the intensity of the local
antigen-specific T-cell response and microbial load could in-
fluence the ability of T cells to control epithelial colonization
by chlamydiae. In these studies, the effects of varying MoPn
inocula with a constant number of cells of the protective T-cell
clone 2.14-0 and varying numbers of T cells with a fixed MoPn
inoculum were investigated in the PELC system. Replicate
cultures of polarized epithelial cells were established in Trans-
well plates. One set of cultures was infected with various
inocula of MoPn (from 105 to 101 IFU per well) and exposed
to a fixed number of clone 2.14-0 cells (2.5 x 106 per well) for
48 h. Another set of polarized epithelial cell cultures was
infected with a constant inoculum of MoPn (103 IFU per well)
and then exposed to various numbers of clone 2.14-0 cells (10
to 103 per well) for 48 h. The choice of 103 IFU per well of
MoPn inoculum in the latter set of cultures was based on
preliminary experiments which showed that when this dose was
employed to infect TM3 epithelial cells with exposure to 2.5 x
10 cells of the protective T-cell clone 2.14-0, a reduction of
approximately 2 logs of MoPn IFU over control cultures was
observed. The results revealed that the ability of clone 2.14-0
to inhibit the productive growth of MoPn in polarized epithe-
lial cells was dependent upon the number of clone 2.14-0 cells
in culture and the MoPn inocula employed. Thus, when the
number of clone 2.14-0 cells was increased in cultures relative
to a fixed inoculum of MoPn, the ability of the clone to inhibit
the productive growth of MoPn in epithelial cells was also
increased (Fig. 3). Extremely low numbers of clone 2.14-0, such
as 103 or 104, had no significant inhibitory effect on the growth
of MoPn in epithelial cells as determined by the one-tailed t
test. Conversely, when the MoPn inoculum was steadily in-
creased, the ability of a fixed T-cell population to control the
multiplication of the organism in epithelial cells was reduced at
105 IFU (Fig. 4) (P < 0.0001 for all groups when compared
with the control). The results suggested that an adequate local
T-cell immune response is crucial for an effective antichlamy-
dial T-cell immunity and also that microbial load could over-
whelm the T-cell immunity against chlamydial infection.
Specificity of MoPn inhibition in polarized epithelial cells
by T-cell clone 2.14-0. Since protective T-cell clone 2.14-0 is
biovar specific, that is, is specific for MoPn but not GPIC or C.
trachomatis serovar E, we investigated whether its chlamydial
inhibitory action required MoPn stimulation; in addition, we
sought to determine if the action was directed at MoPn
exclusively or whether bystanding chlamydial agents could be
inhibited by the activated clone. Polarized epithelial cells were
infected with either MoPn or GPIC and cocultured with clone
2.14-0 that had been rested and then restimulated with UV-
inactivated MoPn or GPIC EBs as antigens. An additional set
of control cultures consisted of clone 2.14-0 plus APCs but no
antigen. Figure 5 (left panel) shows that clone 2.14-0 could
inhibit the growth of MoPn only when stimulated with the
homologous antigen (MoPn) but not when stimulated with the
heterologous antigen (GPIC). It is important to observe that
unstimulated clone 2.14-0 (clone plus APC cultures) could not
inhibit the growth of MoPn, indicating that specific antigenic
stimulation is required for the MoPn-inhibitory action of the
clone. Figure 5 (right panel) also shows that when clone 2.14-0
is appropriately activated with MoPn antigen, it is capable of
inhibiting the productive growth of GPIC in polarized epithe-
lial cells (P < 0.0005). There was no significant difference
between the effect of clone 2.14-0 in the unstimulated state
versus that when it was stimulated with GPIC and subsequently
cocultured with MoPn- or GPIC-infected epithelial cells, indi-
cating that clone 2.14-0 was not activated in either case. The
results confirmed our previous observation that clone 2.14-0 is
MoPn specific, requiring MoPn for activation, as measured by
proliferative response and cytokine secretion (8). In addition,
the requirement for specific antigenic stimulation for cytokine
secretion by clone 2.14-0 also suggested that the mechanism of
its antichlamydial action is probably via cytokine secretion
which acts on both homologous and heterologous susceptible
chlamydial agents in the vicinity of the T cell.
Role of epithelial cell-T-cell interaction in T-cell-mediated
control of chlamydial growth in epithelial cells. In order to
assess in more depth the nature of lymphoepithelial interac-
tions required for T-cell control of chlamydial growth in
epithelial cells, we analyzed the requirement for direct contact
or close proximity ofT cells and infected epithelial cells in the
MoPn-inhibitory action of clone 2.14-0. Polarized epithelial
cell cultures were infected with MoPn and then exposed to
clone 2.14-0 either by coculturing or by separating the two cells
with 0.45-, 3.0-, or 8.0-,um-pore-size filters. After 48 h of
incubation, MoPn growth was assessed by tissue culture isola-
tion. The results revealed that the separation of infected
epithelial cells from the T-cell clone by a filter with 0.45-, 3.0-,
or even 8.0-,um pores abrogated the MoPn-inhibitory action of
the clone (data not shown). The results indicate that close
proximity or possibly direct physical contact between infected
epithelial cells and chlamydia-specific T cells may be required
for T-cell action against chlamydial multiplication in epithelial
cells.
DISCUSSION
A PELC system was employed to investigate the ability of
chlamydia-specific T cells to control chlamydial growth in
epithelial cells. The adaptation of the polarized epithelial cell
culture system (46) to testing the antichlamydial function of
specific T cells is an important step in applying an in vitro
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FIG. 2. TEM study of the morphology of chlamydiae and infected epithelial cells following exposure to protective and nonprotective T-cell
clones. MoPn-infected polarized epithelial cells were exposed to protective and nonprotective T cells for 48 h. At the end of the incubation period,
the filters containing the infected epithelial cells were washed and fixed in situ with 2% glutaraldehyde-0.5% paraformaldehyde in 0.1 M cacodylate
buffer for 45 min at 37°C. Fixed filters were cut out and dipped in 2% molten Noble agar to enrobe them. Samples were then sectioned and
processed for TEM as previously described (46). Polarized epithelial cells infected with MoPn in the absence of T cells (A and B) or the presence
of protective clone 2.14-0 (C) or an irrelevant clone, TC08AA-5 (D), are shown. Magnifications: A, X2,000; B, X7,000; C, x7,000; D, X3,000.
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FIG. 3. Effect of T-cell numbers on the ability of clone 2.14-0 to
inhibit the growth of MoPn in polarized epithelial cells. Duplicate
cultures of polarized epithelial cells were infected with a constant
inoculum of MoPn (103 IFU per well) and exposed to various numbers
of clone 2.14-0 cells (107 to 103 per well) for 48 h. MoPn replication
was determined by tissue culture isolation and detection of the
inclusion bodies by the microimmunofluorescence procedure. Results
are expressed as percent inhibition as defined in the legend to Fig. 1.
system to reproduce an in vivo function within a close approx-
imation.
Of the T-cell preparations tested in these studies, only in
vivo-protective T-cell lines and clones could inhibit the pro-
ductive growth of chlamydiae in polarized epithelial cells in
vitro. Also, T cells alone in the absence of B cells were
responsible for chlamydial control in this system, which cor-
roborated previous results obtained from in vivo studies (25,
26, 31, 43-45), namely, that in the murine-MoPn model of
chlamydial disease, T cells can mediate antichlamydial immu-
nity. The present finding with polarized epithelial cultures may
be analogous to the neutralization of chlamydial infectivity in
vitro with specific polyclonal and monoclonal antibodies (15,
16, 47). However, the PELC system provides a more physio-
logically relevant approach to immune control of chlamydial
control because T-cell function is tested in response to immu-
nological stimulation by a specific antigen. It is important that
only T cells capable of transferring protective immunity against
MoPn genital infection in vivo can inhibit the growth of MoPn
in the PELC system. Thus, if protective T cells employ
identical antichlamydial mechanisms in vivo and in vitro, then
the PELC system could provide a suitable model to investigate
the mechanism of chlamydial control by T-cell-mediated im-
munity, which would have in vivo relevance. Indeed, unlike
most frequently used in vitro systems that directly test the
effects of various T-cell-derived components and products on
microbial growth in culture, the present system would provide
information on the cellular and molecular requirements for
chlamydial control by the immune system.
Additional information derived from these studies is that not
all T-cell clones may be capable of antichlamydial action and,
since different clones may recognize distinct T-cell epitopes, it
appears that not all T-cell epitopes would elicit protective
105 10 103 102 101
MoPn Inocula (IFU)
FIG. 4. Effect of MoPn inocula on the ability of clone 2.14-0 to
inhibit the growth of MoPn in polarized epithelial cells. Duplicate
cultures of polarized epithelial cells were infected with various inocula
of MoPn (from 105 to 101 IFU per well) and exposed to a fixed number
of clone 2.14-0 cells (2.5 x 10' per well) for 48 h. MoPn replication was
determined by tissue culture isolation and detection of the inclusion
bodies by the microimmunofluorescence procedure. The control cul-
ture was infected with 103 IFU of MoPn but no T cells. Results are
expressed as percent inhibition as defined in the legend to Fig. 1.
T-cell immunity. The observations that not all antichlamydial
T-cell clones could cure genital chlamydial infection when
adoptively transferred into infected mice (8) and that not all
defined T-cell epitopes of chlamydial (1, 39) or streptococcal
(14, 41) antigens could provide help for antibody synthesis in
vivo corroborate this point. The significance of distinguishing
protective and nonprotective T-cell epitopes in peptide vaccine
development cannot be overemphasized. Furthermore, if in
vitro antichlamydial action of T cells is a reflection of in vivo
ability to confer antichlamydial immunity, the PELC model
system may provide a rapid in vitro method for testing
protective T-cell clones as well as identifying protein antigenic
fragments harboring protective T-cell epitopes by the ability of
such fragments to stimulate chlamydia-immune T cells to
inhibit chlamydial growth in epithelial cells. Such antigenic
peptides containing protective T-cell epitopes may have pep-
tide vaccine potential. The PELC system also provides a clean
model to test the roles of the various immune cells, including
natural killer cells, -y/8 T cells, purified B cells or T cells, and
the subsets and subtypes, such as Thl and Th2, in antichlamy-
dial immunity.
Previous studies in this laboratory (29) and in others (20, 34,
42) have shown that specific cytokines, such as IFN--y and
TNF-ot, elaborated during chlamydial infection, are involved in
resolving the infection. Our present results appear to indicate
that the mechanism of inhibition of chlamydial growth in
epithelial cells probably involved close-range molecular and/or
cellular interaction between T cells and infected epithelial
cells. Close proximity between T cells and epithelial cells may
be required for short-range action of antichlamydial cytokines
elaborated by the T cells. The present findings further indi-
cated that following immune elicitation in the serosal segment
of the genital or ocular mucosa, the elicited T cells do not
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MoPn
2.14-0 2.14-0 2.14-0
MoPn GPIC APC only
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2.14-0 2.14-0 2.14-0
MoPn GPIC APC only
FIG. 5. Specificity of MoPn inhibition in polarized epithelial cells by T-cell clone 2.14-0. Polarized epithelial cells were infected with either
MoPn or GPIC and cocultured with clone 2.14-0 that had been rested and restimulated with UV-inactivated MoPn or GPIC EBs. A set of cultures
had nonstimulated clone 2.14-0. Both MoPn-infected (left panel) and GPIC-infected (right panel) cultures were incubated for 48 h, and the growth
of the chlamydial agent was determined by tissue culture isolation. Control cultures had no T cells. Results are expressed as percent inhibition as
defined in the legend to Fig. 1.
remain in the submucosal region but appear to migrate into the
epithelium, interacting closely with infected epithelial cells,
possibly via short-range-acting cytokines, before the infection
can be terminated. The short-range activity of T-cell immune
effectors against epithelial pathogens may underscore the need
for local elicitation of mucosal immune responses to control
mucosally acquired pathogens (2). A role for cytokines in medi-
ating the antichlamydial action of T cells is suggested by results
showing that specific antigenic stimulation is required for both
cytokine secretion (8, 9) and antichlamydial action (Fig. 5).
Specific lymphoepithelial interactions associated with geni-
tal or ocular exposure to chlamydiae have been reported (22,
23, 38). These interactions were implicated in chlamydial
control because of the absence of inclusions in areas of the
epithelium with detectable association between epithelial cells
and immigrant lymphocytes (22). It therefore appears that
close interactions between epithelial cells and immune T cells
are required for antichlamydial action of T cells elicited against
chlamydial infection. Lymphocyte activity in mucosal epithelia
has been shown to be antigen driven (5) and is predominantly
T-cell activity (33), even during chlamydial infection (22).
Apart from pathogen control, T cells are also involved in the
regulation of epithelial cell differentiation and function, which
may be mediated at least by IFN--y (35). Other epithelial events
influenced by T cells include the increase of major histocom-
patibility complex class II antigen expression and enhanced
production and expression of the secretory component used
for secretory immunoglobulin A transportation into exocrine
fluids (35). Since most of these T-cell functions are cytokine
mediated (3), lymphoepithelial interactions leading to modu-
lation of epithelial activity or immune control of epithelial
colonization by mucosa-routed pathogens may require close
proximity of T cells and epithelial cells for the efficacy of
short-range-acting cytokines.
In addition to the need for close proximity between T cells
and infected epithelial cells, these studies also indicated that
the continuous presence of an adequate T-cell response (pos-
sibly a high frequency of antigen-specific T cells) in the
mucosal environment is required to ensure resolution of
disease and obviously immunity to reinfection. Inadequate
T-cell activity in the epithelium, as in the case of decreasing the
number of T cells in culture, reduces T-cell control of chla-
mydial colonization and growth in the epithelium and may
explain the inability of athymic nulnu mice to resolve genital
chlamydial infection (30). This observation is further sup-
ported by a previous report that susceptibility to chlamydial
genital infection was associated with the disappearance of
chlamydia-specific T cells in the genital mucosae (10). It
appears that during the course of chlamydial infection specific
ligand-receptor interactions between T cells and epithelial cells
are required to ensure that the T cells remain in close
proximity to the infected epithelial cells in order to ensure an
effective T-cell function. The molecular mechanism of such
interaction probably depends upon the presence of chlamydial
antigens and specific signaling or homing molecules (18),
among other features.
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